222 related articles for article (PubMed ID: 20214530)
1. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
[TBL] [Abstract][Full Text] [Related]
2. Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.
Clarysse S; Brouwers J; Tack J; Annaert P; Augustijns P
Eur J Pharm Sci; 2011 Jul; 43(4):260-9. PubMed ID: 21570465
[TBL] [Abstract][Full Text] [Related]
3. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
[TBL] [Abstract][Full Text] [Related]
4. Drug supersaturation in simulated and human intestinal fluids representing different nutritional states.
Bevernage J; Brouwers J; Clarysse S; Vertzoni M; Tack J; Annaert P; Augustijns P
J Pharm Sci; 2010 Nov; 99(11):4525-34. PubMed ID: 20845451
[TBL] [Abstract][Full Text] [Related]
5. Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.
Fagerberg JH; Al-Tikriti Y; Ragnarsson G; Bergström CA
Mol Pharm; 2012 Jul; 9(7):1942-52. PubMed ID: 22651218
[TBL] [Abstract][Full Text] [Related]
6. Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid.
Takács-Novák K; Szőke V; Völgyi G; Horváth P; Ambrus R; Szabó-Révész P
J Pharm Biomed Anal; 2013 Sep; 83():279-85. PubMed ID: 23770783
[TBL] [Abstract][Full Text] [Related]
7. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.
Augustijns P; Wuyts B; Hens B; Annaert P; Butler J; Brouwers J
Eur J Pharm Sci; 2014 Jun; 57():322-32. PubMed ID: 23994640
[TBL] [Abstract][Full Text] [Related]
8. Cocrystal Solubilization in Biorelevant Media and its Prediction from Drug Solubilization.
Lipert MP; Roy L; Childs SL; Rodríguez-Hornedo N
J Pharm Sci; 2015 Dec; 104(12):4153-4163. PubMed ID: 26390213
[TBL] [Abstract][Full Text] [Related]
9. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media.
Ottaviani G; Wendelspiess S; Alvarez-Sánchez R
Mol Pharm; 2015 Apr; 12(4):1171-9. PubMed ID: 25665011
[TBL] [Abstract][Full Text] [Related]
10. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
11. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
McPherson S; Perrier J; Dunn C; Khadra I; Davidson S; Ainousah B; Wilson CG; Halbert G
Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
[TBL] [Abstract][Full Text] [Related]
12. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
Enright EF; Joyce SA; Gahan CG; Griffin BT
Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
[TBL] [Abstract][Full Text] [Related]
13. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
Shono Y; Jantratid E; Dressman JB
Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
[TBL] [Abstract][Full Text] [Related]
14. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
Fuchs A; Leigh M; Kloefer B; Dressman JB
Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292
[TBL] [Abstract][Full Text] [Related]
15. Solubility profiling of HIV protease inhibitors in human intestinal fluids.
Wuyts B; Brouwers J; Mols R; Tack J; Annaert P; Augustijns P
J Pharm Sci; 2013 Oct; 102(10):3800-7. PubMed ID: 23939880
[TBL] [Abstract][Full Text] [Related]
16. [The dissolution test in biorelevant media as a prognostic tool for modeling of drug behavior in vivo].
Ramenskaia GV; Shokhin IE; Savchenko AIu; Volkova EA
Biomed Khim; 2011; 57(5):482-9. PubMed ID: 22629598
[TBL] [Abstract][Full Text] [Related]
17. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
[TBL] [Abstract][Full Text] [Related]
18. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies.
Kleberg K; Jacobsen J; Müllertz A
J Pharm Pharmacol; 2010 Nov; 62(11):1656-68. PubMed ID: 21039549
[TBL] [Abstract][Full Text] [Related]
19. Dissolution behavior of various drugs in different FaSSIF versions.
Klumpp L; Leigh M; Dressman J
Eur J Pharm Sci; 2020 Jan; 142():105138. PubMed ID: 31704344
[TBL] [Abstract][Full Text] [Related]
20. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.
Kalantzi L; Persson E; Polentarutti B; Abrahamsson B; Goumas K; Dressman JB; Reppas C
Pharm Res; 2006 Jun; 23(6):1373-81. PubMed ID: 16715357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
